20/20 BIOLABS INC
Q2 2026 13F Holders
Symbol
AIDX
CUSIP
90138K101
Type
Equity
Class
ORD SHS
Num filers
15
Total reported value, excl. options
$297 k
Compare 2026 Q2 to
2026 Q3
2026 Q1
Manager
Report Date
Value ($000)
Shares
Option Type